Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

RCC2 blockade is a potential therapeutic approach in glioblastoma

July 16, 2020

KSQ Therapeutics presents new ubiquitin carboxyl-terminal hydrolase 1 inhibitors

July 16, 2020

HLJ1 as a potential new therapeutic target and biomarker in HCC

July 16, 2020

CDK7 inhibitor Q-901 induces potent tumor growth inhibition in vivo

July 15, 2020

USP18 found to promote lung cancer growth

July 15, 2020

New activin receptor type-1 inhibitors identified at Incyte

July 15, 2020

Celgene discovers androgen receptor degradation inducers

July 15, 2020

TOLREMO therapeutics patents compounds targeting CREBBP and p300 HAT

July 15, 2020

BPI-23314 shows promising activity in xenograft models of hematological malignancies

July 15, 2020

Interim phase I data presented for CTT-1403 in mCRPC

July 14, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...